Role: Internal Medicine Resident | O.R. Tambo MMed Scholar

Affiliation: Makerere University

MMED Project Title: Bacterial causes and anti-bacterial susceptibility patterns of urinary tract infections among adults with diabetes mellitus at Mulago National Referral Hospital: exploring differences by renal function

Bio: Fredrick Bakandonda is a medical doctor who recently completed his postgraduate training in Internal Medicine at Makerere University College of Health Sciences in Kampala, Uganda. He holds a strong foundation in clinical medicine with a focus on the comprehensive care of adult patients across a wide spectrum of acute and chronic conditions commonly encountered in resource-limited settings.

His area of clinical expertise lies in Internal Medicine, where he has developed proficiency in the diagnosis, management, and longitudinal care of complex medical cases. This includes experience in both inpatient and outpatient settings, with particular attention to the interplay between infectious diseases and non-communicable diseases that characterize the dual burden of disease in Uganda and similar contexts.

His research interests centre on two interrelated fields: infectious diseases with a special emphasis on antimicrobial resistance and Diabetes Mellitus. He is particularly interested in understanding the drivers, patterns, associations and clinical consequences of antimicrobial resistance in hospital and community settings, as well as exploring effective strategies for stewardship and improved patient outcomes. In parallel, his interest in Diabetes Mellitus is to examine the epidemiological, clinical, and management challenges of the disease in the Ugandan population, including its intersections with infectious comorbidities and the role of contextual factors in care delivery.

Through his academic and research pursuits, he aims to contribute to evidence-based approaches that strengthen clinical practice, inform policy, and improve health outcomes in settings where the burdens of infection and metabolic disease continue to rise.